How You Get a Diagnosis of Churg-Strauss Syndrome

Getting a diagnosis of Churg-Strauss syndrome can feel a little like trying to solve a medical mystery while your lungs, sinuses, skin, nerves, and immune system are all dropping clues in different rooms. One doctor sees asthma. Another sees allergies. A third notices strange bloodwork. Then someone finally says, “Let’s look at the whole picture,” and the puzzle starts to make sense.

Today, Churg-Strauss syndrome is more commonly called eosinophilic granulomatosis with polyangiitis, or EGPA. Yes, the newer name is a mouthful. No, it will not win any awards for being easy to say at a dinner party. But it is more descriptive: “eosinophilic” refers to high levels of eosinophils, a type of white blood cell; “granulomatosis” refers to inflammatory tissue changes; and “polyangiitis” means inflammation of many blood vessels.

The diagnosis is rarely made from one test alone. Instead, doctors usually combine your symptoms, medical history, physical exam, lab tests, imaging, and sometimes a tissue biopsy. The goal is not only to confirm EGPA, but also to find out which organs are affected and how urgently treatment should begin.

What Is Churg-Strauss Syndrome?

Churg-Strauss syndrome, or EGPA, is a rare form of vasculitis. Vasculitis means blood vessels become inflamed. When blood vessels are irritated and swollen, blood flow can slow down or become restricted, which may damage nearby tissues and organs.

EGPA most often appears in people who already have asthma, allergies, chronic sinus problems, or nasal polyps. It commonly affects the lungs and sinuses, but it can also involve the skin, nerves, heart, kidneys, digestive tract, joints, and other organs. That wide range is one reason diagnosis can take time. EGPA does not always walk into the room wearing a name tag. Sometimes it enters as “my asthma got weird,” “my feet are tingling,” or “why do I keep getting sinus infections?”

Why Diagnosis Can Be Tricky

The early signs of EGPA can look like everyday health problems: asthma, nasal congestion, cough, fatigue, allergies, or sinus pressure. Many people spend months or years treating these symptoms before the disease declares itself more clearly.

Another challenge is that EGPA can affect people differently. One person may have severe asthma and nasal polyps. Another may have numbness in the hands or feet. Someone else may develop a rash, stomach pain, chest symptoms, or abnormal urine tests. Doctors have to separate EGPA from other conditions that can also cause high eosinophils, lung symptoms, allergic disease, or blood vessel inflammation.

That is why diagnosis is usually a step-by-step process rather than a single “aha!” moment. Think of it as building a case file. The more pieces that line up, the stronger the suspicion becomes.

Step 1: A Detailed Medical History

The first major clue is your story. Doctors will ask when symptoms started, how they changed, and whether they came in waves. They may ask about asthma that began in adulthood, worsening asthma, frequent sinus infections, nasal polyps, allergy history, rashes, unexplained fevers, weight loss, nerve symptoms, digestive problems, or chest discomfort.

Symptoms doctors listen for

Common clues that may raise suspicion for Churg-Strauss syndrome include:

• Adult-onset asthma or asthma that suddenly becomes difficult to control
• Chronic sinusitis, nasal congestion, or nasal polyps
• High eosinophil levels on blood tests
• Cough, shortness of breath, or shifting lung infiltrates on imaging
• Numbness, tingling, weakness, or burning pain in the hands or feet
• Skin rash, purplish spots, tender bumps, or hives-like changes
• Abdominal pain, diarrhea, bleeding, nausea, or unexplained digestive symptoms
• Chest pain, palpitations, shortness of breath, or signs of heart inflammation
• Blood or protein in the urine, which may suggest kidney involvement

Not everyone has all of these. In fact, most people do not. The pattern matters more than any single symptom. Asthma plus eosinophilia plus signs of inflammation in another organ system is a combination doctors take seriously.

Step 2: Physical Exam and Specialist Evaluation

During a physical exam, a clinician may listen to your lungs, check your skin, look for sinus or nasal findings, evaluate muscle strength, test reflexes, and ask about sensation changes. If EGPA is suspected, you may be referred to specialists such as a rheumatologist, pulmonologist, allergist/immunologist, neurologist, nephrologist, cardiologist, or ear, nose, and throat doctor.

That may sound like assembling a medical Avengers team, but there is a reason. EGPA can affect multiple organs, and each specialist helps map a different part of the disease. A rheumatologist often coordinates the overall vasculitis evaluation, while other specialists help confirm organ involvement and rule out look-alike conditions.

Step 3: Blood Tests

Blood tests are a central part of diagnosing EGPA. The most important early test is usually a complete blood count with differential, which measures eosinophils. Eosinophils are white blood cells that often rise with allergies, asthma, parasitic infections, drug reactions, and certain blood disorders. In EGPA, eosinophil levels can be significantly elevated.

Common blood tests used in the workup

• CBC with differential: Checks eosinophil count and other blood cell levels.
• Inflammation markers: ESR and CRP may be elevated when inflammation is active.
• ANCA testing: Looks for antineutrophil cytoplasmic antibodies, which are associated with some vasculitis conditions.
• Kidney and liver function tests: Help detect organ involvement and establish a treatment baseline.
• IgE level: May be elevated in allergic and eosinophilic conditions.
• Troponin or BNP: May be ordered if heart involvement is suspected.

ANCA testing deserves a special note. Some people with EGPA are ANCA-positive, often with MPO-ANCA, but many are ANCA-negative. A negative ANCA test does not rule out EGPA. This is one of those medical details that can frustrate patients, because the body apparently did not read the instruction manual.

Step 4: Urine Tests

A urinalysis may seem humble compared with high-tech imaging, but it can be extremely useful. Doctors look for blood, protein, or casts in the urine, which may suggest kidney inflammation. Kidney involvement is less common in EGPA than in some other ANCA-associated vasculitis diseases, but it matters because untreated kidney inflammation can become serious.

Urine testing is also helpful for monitoring. Even after diagnosis, doctors may repeat urine tests to check whether disease activity is improving, stable, or returning.

Step 5: Imaging Tests

Imaging helps doctors see what symptoms and lab results cannot fully explain. A chest X-ray may show lung abnormalities, but a CT scan often provides more detail. EGPA can cause lung infiltrates that may move or change over time. Sinus CT scans may show chronic sinus inflammation or nasal polyp-related changes.

Imaging that may be used

• Chest X-ray: A first look for lung inflammation or infiltrates.
• Chest CT scan: More detailed imaging of lung changes.
• Sinus CT scan: Useful when chronic sinusitis or nasal polyps are part of the picture.
• Echocardiogram: Ultrasound of the heart to assess function and inflammation-related effects.
• Cardiac MRI: May be used when myocarditis or other heart involvement is suspected.

Heart evaluation is especially important because cardiac involvement can be serious, even when symptoms are subtle. If someone with suspected EGPA reports chest pain, palpitations, unexplained shortness of breath, fainting, or unusual fatigue, doctors may look closely at the heart.

Step 6: Lung and Breathing Tests

Because asthma is so common in EGPA, pulmonary function tests may be used to measure airflow and lung capacity. These tests do not diagnose EGPA by themselves, but they help document asthma severity and track response to treatment.

Doctors may also evaluate for other lung conditions that can cause eosinophilia, such as allergic bronchopulmonary aspergillosis, eosinophilic pneumonia, infections, or medication reactions. In other words, the workup is not just about proving EGPA; it is also about making sure another condition is not pretending to be EGPA while wearing a suspiciously convincing mustache.

Step 7: Nerve Testing

Many people with EGPA develop nerve symptoms, especially numbness, tingling, burning pain, foot drop, hand weakness, or symptoms affecting one nerve area more than another. Doctors may call this mononeuritis multiplex when multiple individual nerves are inflamed or damaged.

A neurologist may order nerve conduction studies or electromyography, often shortened to EMG. These tests help identify which nerves are affected and whether symptoms are caused by nerve inflammation, compression, diabetes-related neuropathy, vitamin deficiency, or another problem.

Step 8: Biopsy

A biopsy means removing a small sample of tissue so a pathologist can examine it under a microscope. In EGPA, a biopsy may show blood vessel inflammation, eosinophil-rich inflammation, granulomas, or tissue damage. Common biopsy sites include skin, nerve, muscle, lung, or another affected organ.

Biopsy can be very helpful, but it is not always possible or necessary in every case. The best biopsy target is usually an actively affected and safely accessible area. For example, a skin rash may be easier to sample than lung tissue. Doctors weigh the potential benefit against the risks of the procedure.

Diagnostic Criteria: Helpful, But Not the Whole Story

Doctors may refer to classification criteria from medical organizations such as the American College of Rheumatology and the European Alliance of Associations for Rheumatology. These criteria are especially useful in research, but they are not a substitute for clinical judgment.

Older criteria looked at features such as asthma, eosinophilia, nerve involvement, nonfixed lung infiltrates, sinus abnormalities, and biopsy evidence of eosinophils outside blood vessels. More recent ACR/EULAR classification criteria use a point-based system that includes findings such as obstructive airway disease, nasal polyps, eosinophil count, nerve involvement, biopsy features, and certain ANCA or urine findings.

Here is the key takeaway: criteria can support the diagnosis, but real-world diagnosis depends on the full clinical picture. A person is not a spreadsheet. Although, after enough lab results, it can certainly feel that way.

Conditions Doctors Must Rule Out

Because eosinophils rise in many conditions, doctors usually check for other explanations before settling on EGPA. This process is called differential diagnosis. It may include evaluation for:

• Severe allergic asthma
• Parasitic infections
• Drug reactions
• Allergic bronchopulmonary aspergillosis
• Acute or chronic eosinophilic pneumonia
• Hypereosinophilic syndrome
• Granulomatosis with polyangiitis
• Microscopic polyangiitis
• Certain blood cancers or bone marrow disorders
• Other autoimmune or inflammatory diseases

This is why your doctor may ask about travel, medications, supplements, occupational exposures, infections, allergies, family history, and previous test results. The questions may feel endless, but they help prevent a wrong turn.

When Diagnosis Becomes Urgent

Some EGPA symptoms require prompt medical attention. These include chest pain, severe shortness of breath, fainting, sudden weakness, rapidly worsening numbness, coughing blood, severe abdominal pain, black or bloody stools, signs of stroke, or greatly reduced urination. These symptoms can suggest serious organ involvement.

Early diagnosis and treatment are important because inflammation can cause lasting damage. Treatment decisions depend on disease severity and which organs are involved. Doctors may use corticosteroids, immunosuppressive medications, or targeted biologic therapies, but treatment should be guided by a clinician experienced with vasculitis.

What to Bring to Your Appointment

If you are being evaluated for Churg-Strauss syndrome, preparation can make the visit more productive. Bring a timeline of symptoms, a list of asthma flares, sinus infections, rashes, nerve symptoms, hospital visits, medications, supplements, allergies, and prior lab results. If you have imaging reports, pulmonary function tests, biopsy reports, or specialist notes, bring those too.

A simple symptom timeline can be surprisingly powerful. For example: “Asthma began at age 42, nasal polyps were removed at 44, eosinophils were high in March, foot numbness began in May, rash appeared in June.” That kind of sequence helps doctors see patterns that may be hidden inside separate medical visits.

Questions to Ask Your Doctor

Good questions can help you understand the diagnostic plan. You might ask:

• Do my symptoms suggest EGPA or another eosinophilic condition?
• What was my absolute eosinophil count?
• Do I need ANCA testing?
• Is there evidence that my lungs, nerves, kidneys, heart, skin, or digestive tract are involved?
• Should I see a rheumatologist or vasculitis specialist?
• Do I need imaging, nerve testing, or a biopsy?
• What symptoms should make me seek urgent care?

Writing questions down before the appointment is not overkill. It is strategy. Medical visits can move fast, and nobody wins a prize for remembering everything while sitting on crinkly exam paper.

Experience Section: What the Diagnosis Journey Can Feel Like

The experience of getting a diagnosis of Churg-Strauss syndrome often starts long before anyone says the words “vasculitis” or “EGPA.” Many people first live through a confusing season of symptoms that seem related, then unrelated, then maybe related again. The asthma inhaler helps, but not enough. Sinus infections keep returning like an unwanted subscription service. Fatigue shows up and refuses to leave. A rash appears. A foot tingles. Bloodwork looks odd. Suddenly the problem is no longer just “bad allergies.”

One common experience is feeling bounced between explanations. A patient may be told they have adult-onset asthma, chronic sinusitis, allergic disease, neuropathy, or an unexplained inflammatory issue. Each label may be partly true, but none explains the entire story. This can be emotionally exhausting. People may wonder whether they are overreacting, especially if symptoms come and go. The truth is that rare diseases often look ordinary at first. EGPA does not always announce itself with dramatic entrance music.

Another experience is the shock of seeing eosinophil numbers highlighted on lab reports. Many patients have never heard of eosinophils before. Suddenly this tiny category of white blood cell becomes the star witness. Doctors may repeat the test, compare old lab results, and ask whether eosinophils were high before. This can be both reassuring and unnerving: reassuring because there is finally an objective clue, unnerving because the clue points toward something rare.

The diagnostic process can also involve waiting. Waiting for specialist appointments. Waiting for CT results. Waiting for ANCA testing. Waiting to learn whether a biopsy is needed. During this time, it helps to keep a written record of symptoms, medication changes, asthma attacks, new numbness, rashes, fevers, digestive symptoms, and energy levels. A symptom diary may feel boring, but in a rare disease workup, boring details can become gold.

Patients often describe relief when a doctor finally connects the dots. Relief does not mean the diagnosis is easy to hear. It means the scattered symptoms now have a framework. Instead of treating each flare as a separate inconvenience, the care team can evaluate the disease as a whole. That shift matters. It can lead to faster treatment, better monitoring, and clearer decisions about which organs need protection.

There can also be fear, especially when doctors mention the heart, kidneys, lungs, or nerves. That fear is understandable. EGPA can be serious. But diagnosis is also a turning point. Once doctors know what they are dealing with, they can monitor organ involvement, choose appropriate therapy, and adjust treatment based on response. Many people with EGPA live with ongoing care, periodic testing, and treatment plans tailored to disease activity.

The most useful mindset is partnership. Patients bring the lived experience: what symptoms feel like, when they started, what changed, and what seems abnormal. Clinicians bring testing, pattern recognition, and treatment expertise. Diagnosis happens best when both sides share information clearly. In rare disease medicine, the patient’s story is not small talk. It is evidence.

Conclusion

A diagnosis of Churg-Strauss syndrome, now called eosinophilic granulomatosis with polyangiitis, usually comes from putting many clues together. Doctors look for patterns such as asthma, sinus disease, high eosinophils, lung changes, nerve symptoms, skin findings, kidney abnormalities, heart involvement, and biopsy evidence when available.

There is no single perfect test that confirms every case. Instead, diagnosis requires careful clinical judgment, targeted testing, and attention to organ involvement. If you have adult-onset asthma, chronic sinus problems, high eosinophils, and new symptoms affecting the skin, nerves, lungs, heart, kidneys, or digestive tract, it is worth asking your healthcare provider whether EGPA or another eosinophilic disorder should be considered.

Rare diseases can be frustrating, but a thoughtful diagnosis process can turn a confusing pile of symptoms into a clear plan. And in medicine, a clear plan is a very beautiful thingeven if the disease name still needs a pronunciation guide.